Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors Meeting Abstract

  

Authors:	Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Moyers, J. T.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; Renard, C.; Prabhakar, P.; McLaughlin, L.; He, K.
Abstract Title:	Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors
Meeting Title:	2024 World Conference on Lung Cancer
Keywords:	adoptive cell therapy; lymphocytes; non-small cell lung cancer; tumor-infiltrating
Journal Title:	Journal of Thoracic Oncology
Volume:	19
Issue:	10 Suppl.
Meeting Dates:	2024 Sep 7-10
Meeting Location:	San Diego, CA
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2024-10-01
Start Page:	S390
Language:	English
ACCESSION:	WOS:001337925602210
PROVIDER:	wos
DOI:	10.1016/j.jtho.2024.09.705
Notes:	Meeting Abstract: P4.11D.03 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/221968